Manufacturer Supply Linagliptin and Related Intermediates:
Linagliptin CAS 668270-12-0
Linagliptin Parent Nucleus Intermediate CAS 853029-57-9
8-Bromo-3-Methylxanthine CAS 93703-24-3
8-Bromo-7-(2-butyn-1-yl)-3-methylxanthine CAS 666816-98-4
2-(Chloromethyl)-4-Methylquinazoline CAS 109113-72-6
(R)-3-(Boc-Amino)piperidine CAS 309956-78-3
(R)-(-)-3-Aminopiperidine Dihydrochloride CAS 334618-23-4
1-Bromo-2-Butyne CAS 3355-28-0
| Chemical Name | 8-Bromo-3-Methylxanthine |
| Synonyms | 8-Bromo-3-Methyl-3,7-dihydro-1H-purine-2,6-dione |
| CAS Number | 93703-24-3 |
| CAT Number | RF-PI501 |
| Stock Status | In Stock, Production Scale Up to Tons |
| Molecular Formula | C6H5BrN4O2 |
| Molecular Weight | 245.03 |
| Melting Point | 300℃(lit.) |
| Density | 1.974g/cm3 |
| Brand | Ruifu Chemical |
| Item | Specifications |
| Appearance | White to Light Yellow Powder |
| Purity | ≥99.0% |
| Loss on Drying | ≤0.50% |
| Residue on Ignition | ≤0.50% |
| Single Impurity | ≤0.50% |
| Total Impurities | ≤1.0% |
| Heavy Metals | ≤20ppm |
| Test Standard | Enterprise Standard |
| Usage | Intermediate for Linagliptin (CAS: 668270-12-0) |
Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement.
Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture.
8-Bromo-3-Methylxanthine (CAS: 93703-24-3) is a substituted derivative of of Xanthine. It can be used for the synthesis of Linagliptin (CAS: 668270-12-0), which is a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. It was approved by the U.S. FDA in May 2011 for the treatment of Type 2 diabetes along with diet and exercise.Originator is Boehringer Ingelheim (United States).